US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

AdvisorShares Psychedelics ETF

21.87

+0.88004.19%

Volume:8K

Turnover:169.09K

Market Cap:49.54M

PE:- -

High:21.87

Open:21.18

Low:21.15

Close:20.99

52wk High:27.02

52wk Low:15.63

Shares:2.26M

Float Shares:2.26M

Volume Ratio:0.52

T/O Rate:0.35%

Dividend:1.68

Dividend Rate:7.70%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

BioAge Labs initiates Phase 2 trial for BGE-102

Compass Pathways Announces New Employee Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS

CONNEQT Health issues 93.8 million new shares under compliant capital raising

Alkermes (ALKS), What Is Behind The Fresh Attention?

Simply Wall St.

NRX Pharmaceuticals is Maintained at Buy by Ascendiant Capital

Verrica Pharmaceuticals to present new YCANTH data at upcoming conferences

NRx Defense Systems, NRX Pharma Unit, Wins $11.18 Million DARPA Contract for Depression Treatment Trial

NRX Defense Systems, an NRX Company (Nasdaq:Nrxp) Awarded $11 Million Dollar Darpa Prime Contract to Evaluate Robotic Magnetic Stimulation in Conjunction with NRX-101 for Treatment of Resistant Depression

THOMSON REUTERS

Compass Pathways Names Kelley Boucher Chief People Officer

Lithium Universe shareholders back capital raisings and incentive options

MediciNova reports results from MN-001-NATG-202 Phase 2 trial of MN-001

Provaris Energy plans multi-instrument capital raising on ASX

TALi Digital’s Oversubscribed Share Plan Underscores Investor Support

Vectus Biosystems sets virtual AGM to ratify capital raising and board re‑election

Psychedelic: Optimi completes psilocybin production for Phase 2 trial

Alkermes (ALKS) Gets a Hold from Goldman Sachs

BeOne Medicines Advances Phase 3 Liver Cancer Trial With BGB-B2033

AC Immune Posts Strong Week-100 Phase 2 Data for Parkinson’s Vaccine ACI-7104

Minbos wins shareholder backing for capital raising resolutions

Enova Mining Raises $2 Million to Advance Critical Metals Projects

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.tigrgood.cn/stock/PSIL/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"PSIL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PSIL\",,,,,undefined,":{"symbol":"PSIL","market":"US","secType":"STK","nameCN":"AdvisorShares Psychedelics ETF","latestPrice":21.87,"timestamp":1791566439768,"preClose":20.99,"halted":0,"volume":7841,"delay":0,"changeRate":0.04192472606002871,"floatShares":2264976,"shares":2264976,"eps":0,"marketStatus":"Trading","change":0.88,"latestTime":"10-09 13:21:23 EDT","open":21.18,"high":21.87,"low":21.15,"amount":169089.00088399998,"amplitude":0.034302,"askPrice":22.17,"askSize":100,"bidPrice":21.87,"bidSize":124,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1791576000000},"marketStatusCode":2,"adr":0,"exchange":"ARCA","adjPreClose":20.99,"sharesOutstanding":1184976,"nav":21.291,"aum":48224450.04,"dividendRate":0.076973,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":20.99,"preClose":20.99,"latestTime":"07:00 EDT","volume":16,"amount":335.84,"timestamp":1791543613403,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":20.96,"preClose":20.99,"latestTime":"19:40 EDT","volume":250,"amount":5235.67,"timestamp":1791502820850,"change":-0.03,"changeRate":-0.001429,"amplitude":0.001429},"volumeRatio":0.515991,"impliedVol":0.38,"impliedVolPercentile":0.5857},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PSIL\",,,,,undefined,":{"symbol":"PSIL","floatShares":2264976,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.515991,"shares":2264976,"dividePrice":1.6834,"high":21.87,"amplitude":0.034302,"preClose":20.99,"low":21.15,"week52Low":15.6348,"pbRate":"--","week52High":27.0175,"institutionHeld":0,"latestPrice":21.87,"committee":0.107143,"eps":0,"divideRate":0.076973,"volume":7841,"delay":0,"ttmEps":0,"open":21.18,"prevYearClose":17.17,"prevWeekClose":21.85,"prevMonthClose":22.5,"prevQuarterClose":22.5,"fiveDayClose":21.85,"twentyDayClose":24.7682,"sixtyDayClose":24.27},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PSIL\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"PSIL","amount":1.68387,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"AdvisorShares Psychedelics ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-29","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-29"},{"date":"2025-09-22","symbol":"PSIL","amount":0.02007,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"AdvisorShares Psychedelics ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-29","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-29"},{"date":"2025-06-23","symbol":"PSIL","amount":0.01191,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"AdvisorShares Psychedelics ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-27","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-27"},{"date":"2025-03-21","symbol":"PSIL","amount":0.16343,"announcedDate":"2025-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-21","defaultRemindTime":1742563800000,"name":"AdvisorShares Psychedelics ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-28","payableDate":"2025-03-21","currency":"USD","dateTimestamp":1742529600000,"payDate":"2025-03-28"},{"date":"2024-12-23","symbol":"PSIL","amount":0.05477,"announcedDate":"2024-12-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-23","defaultRemindTime":1734964200000,"name":"AdvisorShares Psychedelics ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-30","payableDate":"2024-12-23","currency":"USD","dateTimestamp":1734930000000,"payDate":"2024-12-30"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PSIL\",market:\"US\",,,undefined,":[{"executeDate":"2022-09-26","recordDate":"2022-09-27","paymentDate":"2022-09-30","value":0.05421,"currency":"USD"},{"executeDate":"2023-09-25","recordDate":"2023-09-26","paymentDate":"2023-09-29","value":0.00336,"currency":"USD"},{"executeDate":"2024-09-23","recordDate":"2024-09-23","paymentDate":"2024-09-30","value":0.1087,"currency":"USD"},{"executeDate":"2024-12-23","recordDate":"2024-12-23","paymentDate":"2024-12-30","value":0.05477,"currency":"USD"},{"executeDate":"2025-03-21","recordDate":"2025-03-21","paymentDate":"2025-03-28","value":0.16343,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PSIL\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PSIL\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2672741591","title":"BioAge Labs initiates Phase 2 trial for BGE-102","url":"https://stock-news.laohu8.com/highlight/detail?id=2672741591","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672741591?lang=en_us&edition=fundamental","pubTime":"2026-10-03 04:54","pubTimestamp":1790974488,"startTime":"0","endTime":"0","summary":"BioAge Labs, Inc. ( ($BIOA) ) just unveiled an update. BioAge Labs announced that the first participant has been dosed in QUELL-DME, a randomized, ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bioage-labs-initiates-phase-2-trial-for-bge-102?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bioage-labs-initiates-phase-2-trial-for-bge-102?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBC","BK4007","PSIL","BIOA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672517716","title":"Compass Pathways Announces New Employee Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2672517716","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672517716?lang=en_us&edition=fundamental","pubTime":"2026-10-02 18:30","pubTimestamp":1790937000,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nTUA2VGXHP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CMPS","BK4139","PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672718355","title":"CONNEQT Health issues 93.8 million new shares under compliant capital raising","url":"https://stock-news.laohu8.com/highlight/detail?id=2672718355","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672718355?lang=en_us&edition=fundamental","pubTime":"2026-10-02 16:08","pubTimestamp":1790928495,"startTime":"0","endTime":"0","summary":"CardieX ( ($AU:CQT) ) just unveiled an announcement. CONNEQT Health has disclosed that it issued 93,752,889 fully paid ordinary shares on 25 Septem...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/conneqt-health-issues-93-8-million-new-shares-under-compliant-capital-raising?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/conneqt-health-issues-93-8-million-new-shares-under-compliant-capital-raising?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672235796","title":"Alkermes (ALKS), What Is Behind The Fresh Attention?","url":"https://stock-news.laohu8.com/highlight/detail?id=2672235796","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672235796?lang=en_us&edition=fundamental","pubTime":"2026-10-02 09:21","pubTimestamp":1790904114,"startTime":"0","endTime":"0","summary":"Alkermes (NasdaqGS:ALKS) is back on investors’ radar after releasing phase 1 proof of concept data for ALKS 7290 in adults with ADHD, showing clinically meaningful symptom improvements and supportive safety findings.\nRecent trading tells a mixed story for Alkermes. The share price is around $40.54, with a 30 day share price return down 14.11% and a 90 day move lower by 25.72%. Yet the year to date share price return is up 43.45% and the 1 year total shareholder return sits at 29.69%,...","market":"us","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice1-card/1788937617532","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice1-card/1788937617532"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-alks/alkermes/news/alkermes-alks-what-is-behind-the-fresh-attention","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-alks/alkermes/news/alkermes-alks-what-is-behind-the-fresh-attention","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","IBRN","MEDX","FBT","ALKS","PSCH","PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672946755","title":"NRX Pharmaceuticals is Maintained at Buy by Ascendiant Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2672946755","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672946755?lang=en_us&edition=fundamental","pubTime":"2026-10-01 17:31","pubTimestamp":1790847060,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/NRXP/analyst-ratings","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NRXP","PSIL","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671204298","title":"Verrica Pharmaceuticals to present new YCANTH data at upcoming conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2671204298","media":"TIPRANKS","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671204298?lang=en_us&edition=fundamental","pubTime":"2026-09-30 20:36","pubTimestamp":1790771793,"startTime":"0","endTime":"0","summary":"Verrica Pharmaceuticals (VRCA) announced that it will present posters on a new analysis of Phase 3 trials of YCANTH and an encore presentation of d...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/verrica-pharmaceuticals-to-present-new-ycanth-data-at-upcoming-conferences-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/verrica-pharmaceuticals-to-present-new-ycanth-data-at-upcoming-conferences-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VRCA","PSIL","BBC","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671206559","title":"NRx Defense Systems, NRX Pharma Unit, Wins $11.18 Million DARPA Contract for Depression Treatment Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2671206559","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671206559?lang=en_us&edition=fundamental","pubTime":"2026-09-30 19:03","pubTimestamp":1790766233,"startTime":"0","endTime":"0","summary":"NRx Defense Systems, NRX Pharma unit, wins $11.18 million DARPA contract for depression treatment trialNRx Defense Systems, a subsidiary of NRX Pharmaceuticals, won a DARPA prime contract worth USD 11","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nNDL5G5YTg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NRXP","LU2095319765.USD","IE00BN0W2W23.USD","SG9999014013.SGD","IE00BQXX3D17.EUR","IE00BQXX3F31.USD","IE00BN0W2T93.GBP","NDAQ","IE00BN0W2V16.EUR","BK4007","IE00BKPKM429.USD","BCDF","IE00BQXX3C00.GBP","LU2210150020.SGD","BK4588","PSIL","LU2210149790.SGD","LU0314104364.USD","BK4112","IE00B64PRP62.GBP","SG9999014039.USD","IE00BGHQF748.EUR","SG9999014021.USD","BK4585","SG9999014005.SGD","IE00B3QW5Z07.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671050332","title":"NRX Defense Systems, an NRX Company (Nasdaq:Nrxp) Awarded $11 Million Dollar Darpa Prime Contract to Evaluate Robotic Magnetic Stimulation in Conjunction with NRX-101 for Treatment of Resistant Depression","url":"https://stock-news.laohu8.com/highlight/detail?id=2671050332","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671050332?lang=en_us&edition=fundamental","pubTime":"2026-09-30 19:00","pubTimestamp":1790766001,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nTUA4TS4GL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PSIL","NRXP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671203212","title":"Compass Pathways Names Kelley Boucher Chief People Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2671203212","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671203212?lang=en_us&edition=fundamental","pubTime":"2026-09-30 18:30","pubTimestamp":1790764240,"startTime":"0","endTime":"0","summary":"Compass Pathways names Kelley Boucher chief people officerCompass Pathways appointed Kelley Boucher as chief people officer, effective today.Role includes oversight of people strategy as the company s","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nNDL7zWWlC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PSIL","BK4548","IE00B19Z9Z06.USD","ALNY","LU0889565916.HKD","BMED","BK4588","LU0114720955.EUR","BK4532","PBE","LU0882574055.USD","IE00B19Z9P08.USD","BK4139","LU0234570918.USD","BK4533","BIIB","CMPS","GNMX","LU0320765992.SGD","BK4585","LU0109394709.USD","IE00B894F039.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671529834","title":"Lithium Universe shareholders back capital raisings and incentive options","url":"https://stock-news.laohu8.com/highlight/detail?id=2671529834","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671529834?lang=en_us&edition=fundamental","pubTime":"2026-09-29 12:27","pubTimestamp":1790656045,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Esports Mogul Limited ( ($AU:LU7) ). Lithium Universe Limited has reported that all resolutions put to sharehol...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lithium-universe-shareholders-back-capital-raisings-and-incentive-options?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lithium-universe-shareholders-back-capital-raisings-and-incentive-options?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","PSIL","LIT","BK4585","SETM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670605236","title":"MediciNova reports results from MN-001-NATG-202 Phase 2 trial of MN-001","url":"https://stock-news.laohu8.com/highlight/detail?id=2670605236","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670605236?lang=en_us&edition=fundamental","pubTime":"2026-09-28 18:15","pubTimestamp":1790590507,"startTime":"0","endTime":"0","summary":"MediciNova (MNOV) announced the topline results from MN-001-NATG-202, a Phase 2 clinical trial evaluating MN-001 for the treatment of hypertriglyce...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/medicinova-reports-results-from-mn-001-natg-202-phase-2-trial-of-mn-001-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/medicinova-reports-results-from-mn-001-natg-202-phase-2-trial-of-mn-001-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HYLG","MEDX","MNOV","NVIB","IDNA","PSIL","BK4139","BBC","GDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670233736","title":"Provaris Energy plans multi-instrument capital raising on ASX","url":"https://stock-news.laohu8.com/highlight/detail?id=2670233736","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670233736?lang=en_us&edition=fundamental","pubTime":"2026-09-28 17:37","pubTimestamp":1790588272,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Provaris Energy Ltd ( ($AU:PV1) ). Provaris Energy has notified the ASX of a proposed capital raising involving...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/provaris-energy-plans-multi-instrument-capital-raising-on-asx?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/provaris-energy-plans-multi-instrument-capital-raising-on-asx?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670443258","title":"TALi Digital’s Oversubscribed Share Plan Underscores Investor Support","url":"https://stock-news.laohu8.com/highlight/detail?id=2670443258","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670443258?lang=en_us&edition=fundamental","pubTime":"2026-09-25 14:58","pubTimestamp":1790319526,"startTime":"0","endTime":"0","summary":"Tali Digital ( ($AU:TD1) ) has provided an announcement. TALi Digital has reported strong investor demand for its latest capital raising, with a sh...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/tali-digitals-oversubscribed-share-plan-underscores-investor-support?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/tali-digitals-oversubscribed-share-plan-underscores-investor-support?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670844861","title":"Vectus Biosystems sets virtual AGM to ratify capital raising and board re‑election","url":"https://stock-news.laohu8.com/highlight/detail?id=2670844861","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670844861?lang=en_us&edition=fundamental","pubTime":"2026-09-25 13:47","pubTimestamp":1790315266,"startTime":"0","endTime":"0","summary":"Vectus Biosystems Limited ( ($AU:VBS) ) just unveiled an update. Vectus Biosystems Limited has called its 2026 Annual General Meeting for 28 Octobe...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vectus-biosystems-sets-virtual-agm-to-ratify-capital-raising-and-board-reelection?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vectus-biosystems-sets-virtual-agm-to-ratify-capital-raising-and-board-reelection?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669449944","title":"Psychedelic: Optimi completes psilocybin production for Phase 2 trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2669449944","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669449944?lang=en_us&edition=fundamental","pubTime":"2026-09-24 22:30","pubTimestamp":1790260228,"startTime":"0","endTime":"0","summary":"In this week’s “Psychedelic,” The Fly’s recurring series focused on psychedelic stock news, The Fly looks back on a production completion, a strate...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/psychedelic-optimi-completes-psilocybin-production-for-phase-2-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/psychedelic-optimi-completes-psilocybin-production-for-phase-2-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSIL","BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669460339","title":"Alkermes (ALKS) Gets a Hold from Goldman Sachs","url":"https://stock-news.laohu8.com/highlight/detail?id=2669460339","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669460339?lang=en_us&edition=fundamental","pubTime":"2026-09-24 19:45","pubTimestamp":1790250329,"startTime":"0","endTime":"0","summary":"Goldman Sachs analyst Andrea Newkirk resumed coverage with a Hold rating on Alkermes today and set a price target of $50.00. According to TipRanks,...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/alkermes-alks-gets-a-hold-from-goldman-sachs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/alkermes-alks-gets-a-hold-from-goldman-sachs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBRN","BK4585","LU2237443895.HKD","LU1791807156.HKD","LU0345770308.USD","ALKS","LU1868836591.USD","LU2237438978.USD","LU2471134796.USD","LU2896262040.SGD","IE00B19Z3581.USD","IE00B19Z3B42.SGD","BK4550","LU1668664300.SGD","LU1144417596.USD","LU0868494708.USD","LU2471134879.HKD","BK4552","FBT","LU2471134523.USD","LU0210536198.USD","LU1868837300.USD","LU0868494617.USD","LU2750360641.GBP","GSX","IE0004091025.USD","LU1868836757.USD","LU2265009873.SGD","PSCH","BK4127","IE0034235188.USD","IE00BSNM7G36.USD","IE0002270589.USD","LU2237443465.HKD","PSIL","LU2237443978.SGD","LU2237443622.USD","BK4516","LU0251131958.USD","BK4533","IE0004086264.USD","LU1894683264.USD","LU2471134952.CNY","MEDX","BK4588","BK4504","LU1894683348.USD","LU1868837136.USD","LU0742534661.SGD","LU1804176565.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669480110","title":"BeOne Medicines Advances Phase 3 Liver Cancer Trial With BGB-B2033","url":"https://stock-news.laohu8.com/highlight/detail?id=2669480110","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669480110?lang=en_us&edition=fundamental","pubTime":"2026-09-24 00:31","pubTimestamp":1790181069,"startTime":"0","endTime":"0","summary":"BeOne Medicines ($ONC) announced an update on their ongoing clinical study. BeOne Medicines has launched a Phase 3 trial titled “A Randomized, Open...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/beone-medicines-advances-phase-3-liver-cancer-trial-with-bgb-b2033?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/beone-medicines-advances-phase-3-liver-cancer-trial-with-bgb-b2033?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBC","BGB","MDCO","PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669488235","title":"AC Immune Posts Strong Week-100 Phase 2 Data for Parkinson’s Vaccine ACI-7104","url":"https://stock-news.laohu8.com/highlight/detail?id=2669488235","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669488235?lang=en_us&edition=fundamental","pubTime":"2026-09-23 19:28","pubTimestamp":1790162930,"startTime":"0","endTime":"0","summary":"AC Immune SA ( ($ACIU) ) has shared an announcement. On September 23, 2026, AC Immune reported that Part 1 of its VacSYn Phase 2 trial of ACI-7104 ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ac-immune-posts-strong-week-100-phase-2-data-for-parkinsons-vaccine-aci-7104?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ac-immune-posts-strong-week-100-phase-2-data-for-parkinsons-vaccine-aci-7104?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4113","PSIL","BBC","ACI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669174902","title":"Minbos wins shareholder backing for capital raising resolutions","url":"https://stock-news.laohu8.com/highlight/detail?id=2669174902","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669174902?lang=en_us&edition=fundamental","pubTime":"2026-09-23 10:52","pubTimestamp":1790131935,"startTime":"0","endTime":"0","summary":"The latest update is out from Minbos Resources Limited ( ($AU:MNB) ). Minbos Resources shareholders have approved all eight resolutions tabled at a...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/minbos-wins-shareholder-backing-for-capital-raising-resolutions?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/minbos-wins-shareholder-backing-for-capital-raising-resolutions?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669617889","title":"Enova Mining Raises $2 Million to Advance Critical Metals Projects","url":"https://stock-news.laohu8.com/highlight/detail?id=2669617889","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669617889?lang=en_us&edition=fundamental","pubTime":"2026-09-23 06:49","pubTimestamp":1790117372,"startTime":"0","endTime":"0","summary":"Enova Mining Limited ( ($AU:ENV) ) just unveiled an update. Enova Mining Limited has expanded its recent capital raising, securing an additional $5...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/enova-mining-raises-2-million-to-advance-critical-metals-projects?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/enova-mining-raises-2-million-to-advance-critical-metals-projects?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSIL","PICK","ENVA","BK4535","BK4166"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":200,"code":"91000000","status":"200"}]}}